Filter Results:
(289)
Show Results For
- All HBS Web
(289)
- News (47)
- Research (184)
- Events (1)
- Multimedia (2)
- Faculty Publications (65)
Show Results For
- All HBS Web
(289)
- News (47)
- Research (184)
- Events (1)
- Multimedia (2)
- Faculty Publications (65)
Page 1 of 289
Results →
- September 2022
- Article
Trends in Remote Patient Monitoring Use in Traditional Medicare
By: Mitchell Tang, Carter Nakamoto, Ariel Dora Stern and Ateev Mehrotra
Remote patient monitoring (RPM), the collection by patients of physiological measurements that are automatically sent to their health care practitioners, has been touted as a promising tool for improving chronic disease management. Interest in RPM has grown because of... View Details
Tang, Mitchell, Carter Nakamoto, Ariel Dora Stern, and Ateev Mehrotra. "Trends in Remote Patient Monitoring Use in Traditional Medicare." JAMA Internal Medicine 182, no. 9 (September 2022): 1005–1006.
- November 2023
- Article
Effects of Remote Patient Monitoring Use on Care Outcomes Among Medicare Patients with Hypertension
By: Mitchell Tang, Carter Nakamoto, Ariel Dora Stern, Jose Zubizarreta, Felippe Marcondes, Lori Uscher-Pines, Lee Schwamm and Ateev Mehrotra
Background: Remote patient monitoring (RPM) is a promising tool for improving chronic disease management. Use of RPM for hypertension monitoring is growing rapidly, raising concerns about increased spending. However, the effects of RPM are still... View Details
Tang, Mitchell, Carter Nakamoto, Ariel Dora Stern, Jose Zubizarreta, Felippe Marcondes, Lori Uscher-Pines, Lee Schwamm, and Ateev Mehrotra. "Effects of Remote Patient Monitoring Use on Care Outcomes Among Medicare Patients with Hypertension." Annals of Internal Medicine 176, no. 11 (November 2023): 1465–1475.
- 2022
- Article
Rapid Growth of Remote Patient Monitoring Is Driven by a Small Number of Primary Care Providers
By: Mitchell Tang, Ateev Mehrotra and Ariel Dora Stern
Growing enthusiasm for remote patient monitoring has been motivated by the hope that it can improve care for patients with poorly controlled chronic illness. In a national commercially insured population in the U.S., we found that billing for remote patient monitoring... View Details
Keywords: Remote Monitoring; Medical Billing; Health Care Costs; Telehealth; Diabetes; Chronic Disease; Insurance Claims; Diseases; Primary Care Providers; COVID-19 Pandemic; Health Care and Treatment; Insurance; Cost; Health Industry; United States
Tang, Mitchell, Ateev Mehrotra, and Ariel Dora Stern. "Rapid Growth of Remote Patient Monitoring Is Driven by a Small Number of Primary Care Providers." Health Affairs 41, no. 9 (2022): 1248–1254.
- 10 Aug 2015
- Research & Ideas
New Medical Devices Get To Patients Too Slowly
device was defined using the FDA's standard as one that "supports or sustains human life or is of substantial importance in preventing impairment of human health or presents a potential, unreasonable risk of illness or injury.") The... View Details
- Forthcoming
- Article
Challenges and Facilitators in Implementing Remote Patient Monitoring Programs in Primary Care
By: Ruth Hailu, Jessica Sousa, Mitchell Tang, Ateev Mehrotra and Lori Uscher-Pines
Background: The COVID-19 pandemic resulted in greater use of remote patient monitoring (RPM). However, the use of RPM has been modest compared to other forms of telehealth.
Objective: To identify and describe barriers to the implementation of RPM among primary... View Details
Objective: To identify and describe barriers to the implementation of RPM among primary... View Details
Hailu, Ruth, Jessica Sousa, Mitchell Tang, Ateev Mehrotra, and Lori Uscher-Pines. "Challenges and Facilitators in Implementing Remote Patient Monitoring Programs in Primary Care." Journal of General Internal Medicine (forthcoming). (Pre-published online April 23, 2024.)
- 2022
- Working Paper
Responding Strategically to Competitors' Failures: Evidence from Medical Device Recalls & New Product Submissions
By: George P. Ball, Jeffrey T. Macher and Ariel Dora Stern
Medical device firms operate at the frontiers of innovation. When functioning properly, innovative medical devices can prolong and improve lives; when malfunctioning, the same devices may harm patients and lead to product recalls. Product recalls create significant... View Details
Keywords: New Product Development; Recalls; Product Failures; Medical Devices; FDA; Health Care; Product Development; Product; Failure; Competition; Opportunities; Medical Devices and Supplies Industry
Ball, George P., Jeffrey T. Macher, and Ariel Dora Stern. "Responding Strategically to Competitors' Failures: Evidence from Medical Device Recalls & New Product Submissions." Harvard Business School Working Paper, No. 19-028, September 2018. (Revised March 2022.)
- June 2020
- Article
Evaluation of Prescription Drug Monitoring Program Integration with Hospital Electronic Health Records by US County-Level Opioid Prescribing Rates
By: A Jay Holmgren and Nate Apathy
Prescription drug monitoring programs (PDMPs) have become a widely embraced policy solution to the opioid epidemic in the US. PDMPs offer prescribers a comprehensive view of patients’ controlled substance prescription history and can be used to monitor and reduce... View Details
Keywords: Prescription Drug Monitoring Programs; PDMPs; Electronic Health Records; Hospitals; Health Care and Treatment; Information Technology; Integration; Performance Evaluation
Holmgren, A Jay, and Nate Apathy. "Evaluation of Prescription Drug Monitoring Program Integration with Hospital Electronic Health Records by US County-Level Opioid Prescribing Rates." JAMA Network Open 3, no. 6 (June 2020).
- Article
Regulatory, Legal, and Market Aspects of Smart Wearables for Cardiac Monitoring
By: Jan Benedikt Brönneke, Jennifer Müller, Konstantinos Mouratis, Julia Hagen and Ariel Dora Stern
In the area of cardiac monitoring, the use of digitally driven technologies is on the rise. While the development of medical products is advancing rapidly, allowing for new use-cases in cardiac monitoring and other areas, regulatory and legal requirements that govern... View Details
Keywords: Wearables; Regulatory Changes; Medical Technology; Medical Devices; Market Access; Market Entry and Exit; Information Technology; Health Care and Treatment; Governing Rules, Regulations, and Reforms; United States; Germany; Belgium
Brönneke, Jan Benedikt, Jennifer Müller, Konstantinos Mouratis, Julia Hagen, and Ariel Dora Stern. "Regulatory, Legal, and Market Aspects of Smart Wearables for Cardiac Monitoring." Art. 4937. Sensors 21, no. 14 (July 2021).
- April 15, 2021
- Article
Remote Patient Monitoring—Overdue or Overused?
By: Keizra Mecklai, Nicholas Smith, Ariel Dora Stern and Daniel B. Kramer
As the use of remote patient monitoring services grows—driven by health care limitations imposed by the COVID-19 pandemic—clinicians, payers, and patients face important questions regarding the volume, value, and appropriate use of this care model. View Details
Mecklai, Keizra, Nicholas Smith, Ariel Dora Stern, and Daniel B. Kramer. "Remote Patient Monitoring—Overdue or Overused?" New England Journal of Medicine 384, no. 15 (April 15, 2021): 1384–1386.
- Other Article
How to Make Remote Monitoring Tech Part of Everyday Health Care
By: Samantha F. Sanders, Ariel Dora Stern and William J. Gordon
Remote patient monitoring is a subset of telehealth that involves the collection, transmission, evaluation, and communication of patient health data from electronic devices. These devices include wearable sensors, implanted equipment, and handheld instruments. During... View Details
Keywords: Health Care and Treatment; Information Technology; Analytics and Data Science; Technology Adoption
Sanders, Samantha F., Ariel Dora Stern, and William J. Gordon. "How to Make Remote Monitoring Tech Part of Everyday Health Care." Harvard Business Review (website) (July 2, 2020).
- September 2008 (Revised March 2020)
- Supplement
Medtronic: Patient Management Initiative (B)
The (B) case provides the denouement to the (A) case about Medtronic's introduction of the Chronicle and remote monitoring business. View Details
Keywords: Health Care and Treatment; Measurement and Metrics; Information Technology; Competitive Strategy; Medical Devices and Supplies Industry
Herzlinger, Regina E. "Medtronic: Patient Management Initiative (B)." Harvard Business School Supplement 309-064, September 2008. (Revised March 2020.)
- 05 Mar 2015
- News
Wearable Tech Enables New Era of Employee Monitoring
- 28 Nov 2016
- Research & Ideas
Challenging the Belief that Liability Laws Kill Medical Device Innovation
in passing tort reform laws to limit the amount of damages patients can receive. Less attention has been paid to the effect such reforms can have on medical device innovation. Under the chilling effect of... View Details
- September 2012 (Revised May 2015)
- Case
Philips-Visicu
By: Regina E. Herzlinger, Natalie Kindred and Sara M. McKinley
Would the advent of global payment models and ACOs create sufficient demand for a telemedicine offering covering the care continuum, from hospitals to the home? This was the decision facing Royal Philips Electronics (Philips), the Netherlands-based producer of... View Details
Keywords: Health Care; Philips; Visicu; Telemedicine; eICU; Accountable Care Organization; ACO; Bundled Payment; Hospital To Home; Patient Monitoring Devices; Home Health Care; Health Care and Treatment; Communication Technology; Quality; Safety; Performance Productivity; Performance Capacity; Performance Efficiency; Consumer Behavior; Emerging Markets; Health Industry; Telecommunications Industry; Netherlands
Herzlinger, Regina E., Natalie Kindred, and Sara M. McKinley. "Philips-Visicu." Harvard Business School Case 313-015, September 2012. (Revised May 2015.) (As companion reading for this case, see Regina E. Herzlinger and Charles Huang, "Note on Bundled Payment in Health Care," HBS No. 312-032 (Boston: Harvard Business Publishing, 2012).)
- 02 Jul 2020
- News
How to Make Remote Monitoring Tech Part of Everyday Health Care
- 22 Jul 2014
- Working Paper Summaries
Banks as Patient Fixed-Income Investors
- July 2001 (Revised March 2020)
- Case
Medtronic: Patient Management Initiative (A)
By: Regina E. Herzlinger and Mark P. Allyn
Herzlinger, Regina E., and Mark P. Allyn. "Medtronic: Patient Management Initiative (A)." Harvard Business School Case 302-005, July 2001. (Revised March 2020.)
- May 2024
- Article
Tepid Uptake of Digital Health Technologies in Clinical Trials by Pharmaceutical and Medical Device Firms
By: Caroline Marra and Ariel D. Stern
Digital health technologies (DHTs) can enable more patient-centric therapeutic development by generating evidence that captures how patients feel and function, enabling decentralized trial designs that increase participant inclusivity and convenience, and collecting... View Details
Keywords: Health Care and Treatment; Technological Innovation; Product Development; Health Testing and Trials; Governing Rules, Regulations, and Reforms
Marra, Caroline, and Ariel D. Stern. "Tepid Uptake of Digital Health Technologies in Clinical Trials by Pharmaceutical and Medical Device Firms." Clinical Pharmacology & Therapeutics 115, no. 5 (May 2024): 988–992.
- March 2021 (Revised January 2022)
- Case
Philips: Redefining Telehealth
By: Regina E. Herzlinger, Alec Petersen, Natalie Kindred and Sara M. McKinley
As one of the world’s largest healthcare companies, Philips sought to reach beyond the walls of the hospital and expand its hospital-to-home program to gain future competitive advantage through technology solutions combining predictive analytics with care delivery. By... View Details
Keywords: Health Care; Philips; Visicu; Telemedicine; eICU; Accountable Care Organization; ACO; Bundled Payment; Hospital To Home; Patient Monitoring Devices; Home Health Care; Health Care and Treatment; Communication Technology; Quality; Safety; Performance Productivity; Performance Capacity; Performance Efficiency; Consumer Behavior; Emerging Markets; Health Industry; Telecommunications Industry; Netherlands
Herzlinger, Regina E., Alec Petersen, Natalie Kindred, and Sara M. McKinley. "Philips: Redefining Telehealth." Harvard Business School Case 321-135, March 2021. (Revised January 2022.) (As companion reading for this case, see: Regina E. Herzlinger and Charles Huang. "Note on Bundled Payment in Health Care," HBS Background Note 312-032.)